My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

74.98 +0.31 (+0.42%)
Official Closing Price Updated: 7:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
This Healthcare Stock Is Soaring
CVS is firing on all cylinders. 
Via The Motley Fool
Topics Economy
Q2 Earnings Highs And Lows: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at McKesson (NYSE:MCK) and the best and worst... 
Via StockStory
Why CVS Health (CVS) Stock Is Up Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 2.9% in the afternoon session after broad positive sentiment in the healthcare sector was supported by a bullish analyst outlook. 
Via StockStory
Stock Of The Day: Is CVS Headed Higher?
CVS Health Corporation reverses off of support around the $70 level. There is support at this level because it was resistance. 
Via Benzinga
Where CVS Health Stands With Analysts
 
Via Benzinga
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
Via Stocktwits
Topics Fraud
3 Overrated Stocks with Warning Signs
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. 
Via StockStory
Reflecting On Health Insurance Providers Stocks’ Q2 Earnings: Oscar Health (NYSE:OSCR)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Why CVS Health (CVS) Stock Is Falling Today
Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.8% in the afternoon session after two Republican congressmen launched an investigation into the company over concerns it may have... 
Via StockStory
Topics Artificial Intelligence
What's going on in today's session: S&P500 movers
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Monday as we examine the latest happenings in today's session. 
Via Chartmill
Discover which S&P500 stocks are making waves on Monday.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices. 
Via Benzinga
3 Value Stocks We Approach with Caution
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Federal Reserve on the Brink: What to Expect from the September Interest Rate Decision
As the financial world braces for the highly anticipated Federal Open Market Committee (FOMC) meeting on September 16-17, 2025, market participants are largely anticipating a significant shift in... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
Are Markets Open On Labor Day? Here's What's Open And What's Closed On September 1
Are markets open on Labor Day 2025? Learn what's open and closed on Sept 1, from stocks to stores. Plan your holiday with our guide! 
Via Benzinga
Health Insurance Providers Stocks Q2 In Review: Clover Health (NASDAQ:CLOV) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
3 Spectacular Stocks You Can Buy Now and Hold Forever
The ultimate long-term investing strategy is buying stocks and holding them forever. 
Via The Motley Fool
Stock Market Today: Walgreens Stock Edges Lower as Buyout Nears
Walgreens Boots Alliance shares slipped slightly on Tuesday as investors adjusted positions ahead of its planned private equity deal. 
Via The Motley Fool
Topics Stocks
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon. 
Via Benzinga
Topics Stocks
3 Inflated Stocks We’re Skeptical Of
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Topics Cannabis
2 Safe Dividend Stocks to Buy Now That Could Help You Protect and Grow Your Wealth
These low-risk stocks can provide you with reliable and steadily growing passive income. 
Via The Motley Fool
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
The drug is soon to launch in Europe with a new name and a big potential market. 
Via Investor's Business Daily
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access. 
Via Benzinga
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Insurance coverage is key for any new drug. But it's looking tenuous for Gilead Sciences' newest HIV prevention drug. 
Via Investor's Business Daily
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties. 
Via Benzinga
Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Winners And Losers Of Q2: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Elevance Health (NYSE:ELV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
Michael Burry and Warren Buffett invested in UnitedHealth, signaling confidence in its sector and potential for earnings recovery by 2027. 
Via Benzinga
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.